arrow_back Back to App

Capping US Prescription Drug Prices Based on International Averages

This bill aims to lower prescription drug costs for Americans by setting a price ceiling. The retail list price of a drug in the US cannot exceed the average price of that same drug across six major developed nations. Manufacturers who violate this cap face substantial financial penalties, intended to enforce lower pricing.
Key points
US retail drug prices must not exceed the average price found in Canada, France, Germany, Italy, Japan, and the UK.
The goal is to reduce personal healthcare spending on expensive medications by linking US prices to international rates.
Manufacturers exceeding the price cap face a penalty equal to ten times the price difference for every unit sold.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_S_1218
Sponsor: Sen. Hawley, Josh [R-MO]
Process start date: 2023-04-19
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Fair Prescription Drug Prices for Americans Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_S_1218.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2023-04-19.

What are the main provisions?

Key points include:

  • US retail drug prices must not exceed the average price found in Canada, France, Germany, Italy, Japan, and the UK.
  • The goal is to reduce personal healthcare spending on expensive medications by linking US prices to international rates.
  • Manufacturers exceeding the price cap face a penalty equal to ten times the price difference for every unit sold.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Hawley, Josh [R-MO].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

CATEGORIES

Health